07-22-2008, 01:09 PM
AP - In the latest disappointment for cholesterol pill Vytorin, a major European study in patients with heart valve disease found the drug didn't prevent worsening of the disease or lower the need for valve surgery, sending its makers' stock plunging.
Posted on Mon, 21 Jul 2008 21:34:37 GMT at http://us.rd.yahoo.com/dailynews/rss/hea...ng_vytorin
Posted on Mon, 21 Jul 2008 21:34:37 GMT at http://us.rd.yahoo.com/dailynews/rss/hea...ng_vytorin